Skip to main content

Specialty Pharmacy

  • Kroger closes deal on acquistion of 2nd-largest independent specialty pharmacy

    PALO ALTO, Calif. - Altamont Capital Partners on Wednesday announced that its specialty pharmacy Modern Healthcare was successfully sold to Kroger.

    "We think Kroger is going to be a winner in the health and wellness market, and we are excited to see what they build from this point forward," commented Casey Lynch, Altamont managing director.   

  • Express Scripts rolls out value program around inflammatory conditions

  • ScriptPro streamlines will-call, documentation pain points

    As pharmacies fill more prescriptions, while also needing to provide specialty clinical services, pharmacy technology company ScriptPro is positioning itself as a provider of solutions that will ease common pain points that come with increased script volume and the influx of paperwork from clinical services. ScriptPro’s CEO Mike Coughlin shared two forthcoming innovations from the company with Drug Store News, one of which addresses pharmacy documentation needs, and the other of which will help with pain points in the will-call process.

  • Diplomat extends oncology campaign

    FLINT, Mich. — Diplomat Pharmacy will be extending its campaign to grow awareness of its role in the oncology market while honoring pateints who suffer from cancer, the company announced Wednesday. The campaign will focus on multiple myeloma in September. 
     

  • Allergan expands eye care pipeline with acquisition

    DUBLIN and ANN ARBOR, Mich. — Allergan announced Tuesday that it had acquired substantially all of the assets of RetroSense Therapeutics, a clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision for patients with blindness. The acquisition saw Allergan pay RetroSense a $60 million upfront payment, with the promise of potential regulatory and commercialization milestone payments for the company’s lead development program, RST-001 — a potential therapy for retinitis pigmentosa. 
     

  • Report: Biosmilar regulatory pathway promising but there are sill barriers

  • Walgreens creates strategic alliance with PBM Prime Therapeutics

    DEERFIELD, Ill. – Walgreens and PBM Prime Therapeutics on Monday introduced a new model that aligns pharmacy, PBM and health plans to coordinate patient care, improve health outcomes and deliver cost of care opportunities. The two companies announced a long-term strategic partnership Monday that combines Walgreens' massive pharmacy network with the fourth-largest pharmacy benefit manager.

  • Pfizer aims to strengthen oncology position with Medivation acquisition

     
    NEW YORK and SAN FRANCISCO — Pfizer on Monday announced that it would be acquiring biopharmaceutical company Medication in a cash deal valued at about $14 billion. The acquisition of Medivation, which is focused on developing and commercializing small molecules for oncology, I expected to have an immediately accretive impact on Pfizer’s adjusted diluted earnings per share upon closing, though Pfizer doesn’t anticipate it having an impact on its 2016 financial guidance. 
     
X
This ad will auto-close in 10 seconds